Baronova secures $7.5 million in Series B funding
3 pages —
Published Oct 23, 2008
| | |
| Abstract: | Baronova, Inc., a US-based developer of nonsurgical and nonpharmacologic therapies to treat obesity, has secured $7.5 million in Series B funding round led by Allergan, Inc. Existing investors Arboretum Ventures, Highland Capital Partners and Onset Ventures are also participated in the funding round. |
| | |
| Source: | |
| Document ID | MA00316_081025 |
| Country | |
| Free Sample: | |
| Format: | | PDF |  |
|
MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.
